Purpose
To test the hypothesis that treatment with a high dose of alpha-tocopherol would reduce subsequent risk of myocardial infarction
(MI) and cardiovascular (CV) death in patients with established IHD
References
Stephens NG, Parsons A, Schofield PM, et al: Randomised controlled trial of vitamin E in patients with coronary
disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781–786.
|
Farmacêutica